DESIGN. ANALYZE. ADVANCE.
LIVE

Serial Number

99318283

Owner

BIOMEDICAL STATISTICAL CONSULTING IP LLC

Attorney

Marc P. Misthal

First Use Date

Jul 24, 2025

Filing Date

Aug 4, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DESIGN. ANALYZE. ADVANCE. Trademark

Serial Number: 99318283 • Registration: 8300692

DESIGN. ANALYZE. ADVANCE. is a trademark filed by BIOMEDICAL STATISTICAL CONSULTING IP LLC on August 4, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BIOMEDICAL STATISTICAL CONSULTING IP LLC (3 trademarks)

2400 MARKET STREET, SUITE 200
PHILADELPHIA, PA 19103

Entity Type: 16

Trademark Details

Filing Date

August 4, 2025

Registration Date

June 16, 2026

First Use Anywhere

July 24, 2025

First Use in Commerce

July 24, 2025

Published for Opposition

April 28, 2026

Goods & Services

Representation of clients in biomedical and pharmaceutical regulatory proceedings

Promoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries for others regarding clinical trials

Consulting services for pharmaceutical, medical device, biotechnology, and medical research industries; consulting services in the field of expert review of proposed clinical trial design; software as a service (SaaS) featuring software for statistical analysis and simulation tools for clinical trial design, analysis, and optimization; providing an online non-downloadable computer software platform for running in vivo studies; providing an online non-downloadable computer software platform for running in silico studies; data modeling and statistical consulting services for the pharmaceutical, medical device, biotechnology, and medical research industries; design, development and implementation of software for in vivo simulations; design, development and implementation of software for in silico simulations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 16, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 30, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 30, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 30, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 30, 2026 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 4, 2025 MAFR
NEW APPLICATION ENTERED
Aug 4, 2025 NWAP